You are here » Home » Companies » Company Overview » Suven Life Sciences Ltd

Suven Life Sciences Ltd.

BSE: 530239 Sector: Health care
NSE: SUVEN ISIN Code: INE495B01038
BSE LIVE 15:56 | 21 Sep 191.20 7.75
(4.22%)
OPEN

185.95

HIGH

197.95

LOW

181.00

NSE 15:49 | 21 Sep 190.50 7.00
(3.81%)
OPEN

183.70

HIGH

198.20

LOW

181.85

OPEN 185.95
PREVIOUS CLOSE 183.45
VOLUME 230657
52-Week high 213.10
52-Week low 151.10
P/E 20.21
Mkt Cap.(Rs cr) 2,434
Buy Price 191.20
Buy Qty 1426.00
Sell Price 0.00
Sell Qty 0.00
OPEN 185.95
CLOSE 183.45
VOLUME 230657
52-Week high 213.10
52-Week low 151.10
P/E 20.21
Mkt Cap.(Rs cr) 2,434
Buy Price 191.20
Buy Qty 1426.00
Sell Price 0.00
Sell Qty 0.00

Suven Life Sciences Ltd. (SUVEN) - Company History

Incorporated in Mar.'89 as a private limited company, Suven Pharmaceuticals (SPL) was converted into a public limited company in Jan.'95. It was promoted by Jasti Sudha Rani and Jasti Venkateswarlu, who is the present managing director. In Mar.'95, SPL came out with a public issue of 9.8 lac equity shares at a premium of Rs 40 aggregating Rs 4.9 cr to part-finance the company's project for the manufacture of bulk drugs and drug intermediates and meet long-term working capital requirements totalling to Rs 6.43 cr. The company manufactures bulk drugs and drug intermediates -- theophylline, caffeine, nitroso compound, cyanoacetic acid, etc. SPL has a sizeable export turnover through the export of drug intermediates to Germany, Switzerland, Israel, Europe, etc. During 1999-2000, the company has acquired a small pilot plant in Jeedimetla Industrial Estate,Hyderabad. During 2000-01, the company has registered a most remarkable record. The total sales of the company during 2000-01 has registered a growth of 71% over the previous year.The Profit After Tax(PAT) has also registered a growth of 325% over the previous year. The company has successfully achieved the re-certification of ISO 9002 during the year 2000-01. The company is planning to Modernize & Upgrade its R & D at Jeedimetla Industrial Estate.